Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Amneal Eyes Generic Injectables Deals, While Competition Bites Sooner Than Anticipated

Executive Summary

A strengthened cash position has provided Amneal the chance to seek inorganic opportunities to bolster its growing presence in injectables. The US-based, US-centric company is looking to grow its operations, having been surprised in recent weeks by generic competition to its most lucrative generic assets.

You may also be interested in...

US Pricing Pressures Have Stabilized, Insists Teva Chief

Pricing pressures that have affected the US generics market over the last few years have stabilized and this will continue to be the case in the future, according to Teva chief Kåre Schultz. Speaking at the 2019 J.P. Morgan Healthcare Conference, he also revealed that the firm was on track with its restructuring and debt-reduction plan.

What’s Next? Five Things To Look Out For In October

Generics Bulletin previews the most notable and anticipated events for October 2023.

Hybrid Specialist Azurity Snaps Up Complex Generics Firm Slayback Pharma

In an acquisition said by both US-based companies to be highly complementary, Azurity Pharmaceuticals has taken control of Slayback Pharma for an undisclosed fee.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts